Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Change in Account Payables (2016 - 2023)

Historic Change in Account Payables for ProPhase Labs (PRPH) over the last 12 years, with Q3 2023 value amounting to $681000.0.

  • ProPhase Labs' Change in Account Payables rose 12348.28% to $681000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was -$3.3 million, marking a year-over-year increase of 6843.5%. This contributed to the annual value of -$1.6 million for FY2017, which is 23670.67% down from last year.
  • ProPhase Labs' Change in Account Payables amounted to $681000.0 in Q3 2023, which was up 12348.28% from $1.5 million recorded in Q2 2023.
  • ProPhase Labs' Change in Account Payables' 5-year high stood at $1.5 million during Q2 2023, with a 5-year trough of -$5.1 million in Q3 2021.
  • Moreover, its 3-year median value for Change in Account Payables was -$2.7 million (2023), whereas its average is -$1.6 million.
  • The largest annual percentage gain for ProPhase Labs' Change in Account Payables in the last 5 years was 14099.97% (2023), contrasted with its biggest fall of 32589.13% (2023).
  • Quarter analysis of 3 years shows ProPhase Labs' Change in Account Payables stood at -$5.1 million in 2021, then surged by 43.05% to -$2.9 million in 2022, then surged by 123.48% to $681000.0 in 2023.
  • Its Change in Account Payables stands at $681000.0 for Q3 2023, versus $1.5 million for Q2 2023 and -$2.7 million for Q1 2023.